Effect Ayurveda decoctions, tablet and Panchagavya on COVID 19

Action Plan for COVID-19 based on Ayurveda decoctions, tablet and Panchagavya

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/026980

Enrollment

180

Registered

2020-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurveda decoctions, tablet and Panchagavya: Gojihvadi Kwath with 30 ml twice a day on empty stomach Sanjeevani Vati â?? 350 mg twice a day after meal with Fresh zinger juice and hone

Eligibility

Inclusion criteria

Inclusion criteria: Subjects not enrolled in other clinical studies Patients who fulfils the Diagnostic features of COVID â?? 19 (Only symptomatic patients) Laboratory test positive for COVID â?? 19 Age of patients more than 10 years -90 years Both male and female patients.

Exclusion criteria

Exclusion criteria: • Asymptomatic COVID â?? 19 patients will not be included • Seriously ill critical patients • Presenting serious symptoms • Suffering from complications • Age below 10 years • Vulnerable participants

Design outcomes

Primary

Measure	Time frame
Primary outcome: Patient becoming asymptomatic Secondary outcome: COVID 19 RT PCR becoming negative Timepoint: At 7 days and 15 days	—

Secondary

Measure	Time frame
COVID 19 RT PCR becoming negative Timepoint: 7 days and 15 days	—

Countries

India

Contacts

Public ContactParameswarappa Byadgi

Institute of Medical Sciences, BHU

psbyadgi@gmail.com09450711759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026